New Concepts in MRI Contrast Safety and Management

Presented by Ari D. Goldberg, MD, PhD, Medical Director, Body Imaging, Medical Director, MRI, Loyola University Medical Center

MRI contrast agents continue to be developed, with a focus on continued improvements in stability and safety, as well as maximization of image clarity. These distinctions rest in the molecular structure of the particular gadolinium-based contrast agent. Understanding the relative safety and efficacy of these agents is important in the radiologic management of patients. During this webinar, we’ll look closely at novel advances related to MRI contrast safety and management; understanding the risks associated with various agents as well as their efficacy.

In this webinar, attendees will learn how to:

• Identify the different Gadolinium-based contrast agent classifications.
• Explain how Gadolinium-based contrast agent stability and safety is evaluated.
• Describe the concept of gadolinium-based contrast agent "relaxivity".

AHRA Member: free to members
Non-Member: $25.00
Click here to learn more about the benefits of AHRA Membership.